AAA Scientists checking sample 1

At Novartis, we are reimagining medicine

Novartis Financial Results – Q1 2021

Novartis announced the company’s financial results for the first quarter of 2021.

Read More

Building clinical trial diversity for long-term equity

Vas Narasimhan reflects on how to increase diversity in clinical trials.

Read More

COVID-19 US Information Center

Novartis is responding to the coronavirus disease (COVID-19) outbreak. The information center provides a central hub for news, guidance and resources.


Novartis in Society 2020 US Report

Novartis is striving every day to help patients, strengthen communities, drive sustainability, and build a more equitable and responsive healthcare system for all.

Read More

Notice to Healthcare Providers and Entities

Novartis enters into Corporate Integrity Agreement with Office of Inspector General (OIG) of the US Department of Health & Human Services.

Read More

Novartis US at a Glance

Learn more about Novartis in the US and our impact on patients, families and their communities.

Read More

AveXis renamed Novartis Gene Therapies, signifying the growing importance of gene therapy to Novartis corporate strategy

Learn More

Standing for Racial Equity and Justice as One Novartis

We believe unequivocally that Black Lives Matter. As a company focused on improving human health globally, we also recognize the disparities Black communities and communities of color face when it comes to healthcare.

Read More